- Home
- Free App Analytics
- Cancer iChart
- Cancer iChart Vs. UKONS
Cancer iChart vs UKONS Usage & Stats
Healthcare professionals and patients should use this application to search for potential drug-drug interactions between anti-cancer drugs and other medications. Results are presented as a “Traffic Light” system (red, amber, yellow and green) to indicate the recommendation. A brief summary of each interaction is given along with a grading of the quality of evidence (very low, low, moderate, high). The application is available free of charge and has been developed by Radboudumc in Nijmegen, the Liverpool Drug Interactions Group at the University of Liverpool and Clubzap Ltd.
Requirements:
This is an “offline” application that is downloaded to your device. An internet connection is not required to use the application, but is needed for downloading updates.
Why this application may be useful:
Patients with cancer often take medication in addition to cancer therapy either to aid side effects and symptoms, or to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different anti-cancer drugs and other medications that the cancer patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.cancer-druginteractions.org
- Apple App Store
- Free
- Medical
Store Rank
- -
UKONS Acute Oncology Initial Management Guidelines - Version 4.0
Guidelines for the initial management of adult patients who have a cancer diagnosis, and present as an emergency or unplanned admission with a complication of their disease or cancer treatment.
These Guidelines are for the use of medical professionals only. They are not intended for public use, including by oncology patients. UKONS does not permit the creation of derivative works, unless they are authorized.
The information contained in these guidelines is a consensus of the development and consultation groups' views on current treatment. They should be used in conjunction with any local policies/ procedures/ guidelines and should be approved for use according to the trust clinical governance process. Care has been taken in the preparation of the information contained in the guidelines. Nevertheless, any person seeking to consult the guideline, apply its recommendations or use its content is expected to use independent, personal medical and/or clinical judgment in the context of the individual clinical circumstances, or to seek out the supervision of a qualified clinician. The United Kingdom Oncology Nursing Society makes no representation or guarantee of any kind whatsoever regarding the guidelines content or its use or application and disclaim any responsibility for its use or application in any way.
- Apple App Store
- Free
- Medical
Store Rank
- -
Cancer iChart vs. UKONS ranking comparison
Compare Cancer iChart ranking trend in the past 28 days vs. UKONS
Rank
No Data Available
Cancer iChart vs. UKONS ranking by country comparison
Compare Cancer iChart ranking trend in the past 28 days vs. UKONS
No Data to Display
Compare to any site with our free trial
Cancer iChart VS.
UKONS
January 5, 2025